Skip to main content
Tata Chemicals Ltd logo

Tata Chemicals Ltd — Investor Relations & Filings

Ticker · TATACHEM ISIN · INE092A01019 LEI · 335800H6MURUA6FBOW17 BSE.NS Manufacturing
Open in API
Filings indexed 2,743 across all filing types
Latest filing 2024-04-23 Regulatory Filings
Country IN India
Listing BSE.NS TATACHEM

About Tata Chemicals Ltd

https://www.tatachemicals.com/

Tata Chemicals Ltd provides chemistry-led solutions through its Basic Chemistry and Specialty Products segments. It is a leading global producer of soda ash and sodium bicarbonate, serving sectors such as glass, detergents, pharmaceuticals, and food processing. The specialty portfolio includes agro sciences, nutritional sciences, and material sciences, with a focus on prebiotics, highly dispersible silica, and crop protection through its subsidiary, Rallis India. The company operates manufacturing facilities across four continents and invests in energy sciences, specifically lithium-ion battery materials. Its operations are characterized by innovation-driven R&D and sustainable manufacturing practices. By integrating science with sustainability, the company delivers essential ingredients and specialized solutions to a global customer base across industrial and agricultural markets.

Recent filings

Filing Released Lang Actions
Sub: Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is an official communication from Tata Chemicals Limited to stock exchanges (BSE and NSE) regarding the loss of share certificates. It includes notices from the company's Registrar and Transfer Agent (RTA), Link Intime India Private Limited, informing about lost/mislaid share certificates and the process for issuing duplicate certificates. The document references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to reporting loss of share certificates. There is no financial data, earnings information, management discussion, or report publication mentioned. The content is a regulatory compliance announcement about lost share certificates and the issuance of duplicates, which fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2024-04-23 English
We wish to inform that since the pre-registration link provided in the previous letter for the Analysts'/Investors Call on the Audited Consolidated and Standalone Financial Results of the ....
Regulatory Filings Classification · 95% confidence The document is a notification about an upcoming Analysts’/Investors Call scheduled for April 29, 2024, to discuss the Q4 and FY24 financial performance of Tata Chemicals Limited. It includes dial-in details and contact information but does not contain any financial data or results itself. The document is short (2696 characters) and serves as an announcement for the call rather than the call transcript or financial report. Therefore, it fits the category of a Call Transcript (CT) only if it contained the full transcript, which it does not. It is not an Earnings Release (ER) because it does not announce financial results, only the call. The best fit is a Regulatory Filing (RNS) as a general announcement under SEBI regulations about the call details, or possibly a Call Transcript (CT) if it were the transcript. Given the content, the closest specific category is Regulatory Filings (RNS).
2024-04-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification about an upcoming Analysts’/Investors Call scheduled for April 29, 2024, to discuss the Q4 and FY24 financial performance of Tata Chemicals Limited. It includes dial-in details and contact information but does not contain any financial data or results itself. The document is short (2696 characters) and serves as an announcement or intimation of the call rather than the call transcript or financial report. Therefore, it fits the category of a Call Transcript (CT) only if it contained the full transcript, which it does not. It is not an Earnings Release (ER) because it does not announce financial results, only the call. It is not a Report Publication Announcement (RPA) because it does not mention report publication. The best fit is a Regulatory Filing (RNS) as a general regulatory announcement about the call under SEBI regulations.
2024-04-23 English
Board Meeting — TATA CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 29-Apr-2024 to consider and approve the Yearly Audited Financial results of the Company for the peri…
Regulatory Filings
2024-04-19 English
Pursuant to Regulation 30 of the SEBI Listing Regulations, we would like to inform that an Analysts'/Investors Call on the Audited Consolidated and Standalone Financial Results of the Company ....
Regulatory Filings Classification · 95% confidence The document is an intimation letter dated April 19, 2024, from Tata Chemicals Limited to stock exchanges (BSE and NSE) about an upcoming Analysts’/Investors Call scheduled for April 29, 2024. It references the discussion of the Audited Consolidated and Standalone Financial Results for the quarter and year ended March 31, 2024. The document includes dial-in details for the call and contact information for further inquiries. The document is short (2776 characters) and serves as a notification of the call rather than the call transcript or the financial results themselves. Therefore, it is an announcement of an upcoming conference call, not the transcript or the financial report. According to the classification rules, such notifications about calls are best classified as Call Transcript (CT) only if the full transcript is provided. Since this is only an intimation of the call, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and notification under SEBI Listing Regulations.
2024-04-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation notice about an upcoming Analysts’/Investors Call scheduled for April 29, 2024, to discuss the audited consolidated and standalone financial results for the quarter and year ended March 31, 2024. It includes details about the call timing, dial-in numbers, and contact information. The document does not contain any financial data or results itself, but rather announces the event where such information will be discussed. The document length is 2727 characters, which is relatively short and consistent with an announcement rather than a full report or transcript. Therefore, this document is best classified as a Call Transcript announcement or notification, but since it is only an intimation of the call and not the transcript itself, it fits the category of Regulatory Filings (RNS) as a general regulatory announcement under SEBI Listing Regulations.
2024-04-19 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.